We will sequence >100 colorectal cancer genes and 50 copy number regions in >2000 colorectal cancer samples from chemotherapy and radiotherapy clinical trials, with a view to identifying the landscape of driver mutations for each patient’s tumour in order to build, using clinical outcome data, robust predicitve models for personalised cancer medicine.